65219-586Level 3
TYENNE (Tocilizumab-aazg)
**Product type:** Human Prescription Drug
**Active ingredient:** TOCILIZUMAB
**Strength:** 162 mg/.9mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Fresenius Kabi USA, LLC
**Marketing category:** BLA (BLA761275)
**Pharmacologic class:** Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/65219-586Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.